Mark Blundell serves as Executive at MusclePharm Corp, where they oversee executive responsibilities. Since joining the company, Mark Blundell has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 30, 2019 involved purchasing 626,826 shares valued at $0.
Mark Blundell currently holds 3,658,180 shares of MusclePharm Corp (MSLP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Blundell has been a net neutral trader of MSLP stock. They have purchased $0 and sold $0 worth of shares.
Mark Blundell's most recent insider trade was on Sep 30, 2019, when they purchased 626,826 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |